China

Keytruda nabs key lung cancer nod in China. But are blockbuster sales really attainable?
Fierce Pharma
Sat, 03/30/19 - 12:02 am
Merck
Keytruda
China
advanced non-squamous non-small cell lung cancer
China lists 30 more overseas drugs eligible for Priority Review
BioCentury
Fri, 03/29/19 - 10:19 am
China
drug approvals
AstraZeneca to help build new life science research cluster in China
Fierce Biotech
Thu, 03/28/19 - 11:38 am
AstraZeneca
China
R&D
Medtronic launches Shanghai-based medtech incubator
Mass Device
Tue, 03/26/19 - 11:01 pm
Medtronic
devices
Shanghai
China
device company incubators
Novartis launches COPD inhalers in China
Drug Delivery Business News
Fri, 03/22/19 - 11:54 am
Novartis
COPD
China
Ultibro Breezhaler
Seebri Breezhaler
devices
An AIDS therapy involving parasite injections was discredited. China is reviving it — for cancer
Stat
Mon, 03/18/19 - 12:18 pm
Henry Heimlich
China
malarial therapy
cancer
China proposes 50% reimbursement for chronic disease therapies
BioCentury
Fri, 03/15/19 - 08:36 pm
China
reimbursement
chronic disease
Analysts: Keytruda has a blockbuster market not factored into Merck’s forecasts—China
Fierce Pharma
Fri, 03/15/19 - 12:20 pm
Merck
Keytruda
immuno-oncology
China
Novo Nordisk Launches Innovation Platform in China
CP Wire
Fri, 03/8/19 - 09:54 am
Novo Nordisk
China
innovation
Innovo
Novo Nordisk Launches Innovation Platform in China
Fri, 03/8/19 - 09:46 am
Novo Nordisk
China
Following key late-stage advances, BeiGene puts down $10M to get some discovery projects rolling at Ambrx
Endpoints
Wed, 03/6/19 - 10:10 am
BeiGene
China
Ambrx
Novartis data confirm rapid response and high efficacy of Cosentyx in psoriasis patients for first time in China
Pharmaceutical Business Review
Tue, 03/5/19 - 10:00 am
Novartis
Cosentyx
China
psoriasis
Ascletis poaches top MSD China executive as its new R&D chief
Fierce Biotech
Sat, 03/2/19 - 12:43 pm
R&D
China
Ascletis Pharmaceuticals
Gracell raises $85M series B to advance cell therapies
BioCentury
Mon, 02/25/19 - 11:31 pm
Gracell
China
cell therapy
China releases list of rare disease drugs with reduced VAT
BioCentury
Sun, 02/24/19 - 11:24 pm
China
VAT
Rare Diseases
Chinese Immuno-Oncology Company to Raise $282 Million Via Hong Kong IPO
CP Wire
Mon, 02/18/19 - 11:21 am
CStone Pharmaceuticals
IPOs
China
Hong Kong
immuno-oncology
China to Cut Value Added Tax on Rare Disease Drugs to 3%
CP Wire
Wed, 02/13/19 - 10:02 am
China
Rare Diseases
VAT
China to Cut Value Added Tax on Rare Disease Drugs to 3%
Wed, 02/13/19 - 09:38 am
China
Rubio report outlines Chinese threat to U.S. biotech industry
BioCentury
Wed, 02/13/19 - 12:30 am
China
biotech
biosimilars
Marco Rubio
HaiHe raises $147M to advance cancer candidates
BioCentury
Mon, 02/11/19 - 08:14 pm
Shanghai HaiHe Biopharma
China
cancer

Pages